0001209191-20-064433.txt : 20201218 0001209191-20-064433.hdr.sgml : 20201218 20201218163945 ACCESSION NUMBER: 0001209191-20-064433 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201216 FILED AS OF DATE: 20201218 DATE AS OF CHANGE: 20201218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Demski David M CENTRAL INDEX KEY: 0001555392 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 201401092 MAIL ADDRESS: STREET 1: C/O GLOBUS MEDICAL, INC. STREET 2: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-16 0 0001237831 GLOBUS MEDICAL INC GMED 0001555392 Demski David M VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 1 1 0 0 President, CEO Class A Common Stock 2020-12-16 4 M 0 3125 43.77 A 151980 D Class A Common Stock 2020-12-16 4 M 0 3125 43.58 A 155105 D Class A Common Stock 2020-12-16 4 M 0 6250 29.31 A 161355 D Class A Common Stock 2020-12-16 4 M 0 1666 26.27 A 163021 D Class A Common Stock 2020-12-16 4 M 0 31137 25.52 A 194158 D Class A Common Stock 2020-12-16 4 M 0 7053 24.10 A 201211 D Class A Common Stock 2020-12-16 4 S 0 52356 64.20 D 148855 D Class A Common Stock 2020-12-17 4 M 0 15864 24.10 A 164719 D Class A Common Stock 2020-12-17 4 S 0 164719 64.20 D 0 D Stock Option (Right to Buy Class A Common Stock) 43.77 2020-12-16 4 M 0 3125 0.00 D 2028-01-22 Class A Common Stock 3125 50000 D Stock Option (Right to Buy Class A Common Stock) 43.58 2020-12-16 4 M 0 3125 0.00 D 2029-01-22 Class A Common Stock 3125 87500 D Stock Option (Right to Buy Class A Common Stock) 29.31 2020-12-16 4 M 0 6250 0.00 D 2027-08-28 Class A Common Stock 6250 120000 D Stock Option (Right to Buy Class A Common Stock) 26.27 2020-12-16 4 M 0 1666 0.00 D 2027-01-30 Class A Common Stock 1666 78334 D Stock Option (Right to Buy Class A Common Stock) 25.52 2020-12-16 4 M 0 31137 0.00 D 2026-01-25 Class A Common Stock 31137 0 D Stock Option (Right to Buy Class A Common Stock) 24.10 2020-12-16 4 M 0 7053 0.00 D 2025-01-20 Class A Common Stock 7053 15864 D Stock Option (Right to Buy Class A Common Stock) 24.10 2020-12-17 4 M 0 15864 0.00 D 2025-01-20 Class A Common Stock 15864 0 D This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.20 to $64.23, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on August 28, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on August 28, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. /s/ Kelly G. Huller, Attorney-in-Fact 2020-12-18